Journal Title：Medical Microbiology And Immunology

Medical Microbiology and Immunology (MMIM) publishes key findings on all aspects of the interrelationship between infectious agents and the immune system of their hosts. The journal′s main focus is original research work on intrinsic, innate or adaptive immune responses to viral, bacterial, fungal and parasitic (protozoan and helminthic) infections and on the virulence of the respective infectious pathogens.

MMIM covers basic, translational as well as clinical research in infectious diseases and infectious disease immunology. Basic research using cell cultures, organoid, and animal models are welcome, provided that the models have a clinical correlate and address a relevant medical question.

The journal also considers manuscripts on the epidemiology of infectious diseases, including the emergence and epidemic spreading of pathogens and the development of resistance to anti-infective therapies, and on novel vaccines and other innovative measurements of prevention.

The following categories of manuscripts will not be considered for publication in MMIM:

submissions of preliminary work, of merely descriptive data sets without investigation of mechanisms or of limited global interest,

manuscripts on existing or novel anti-infective compounds, which focus on pharmaceutical or pharmacological aspects of the drugs,

manuscripts on existing or modified vaccines, unless they report on experimental or clinical efficacy studies or provide new immunological information on their mode of action,

manuscripts on the diagnostics of infectious diseases, unless they offer a novel concept to solve a pending diagnostic problem,

case reports or case series, unless they are embedded in a study that focuses on the anti-infectious immune response and/or on the virulence of a pathogen.

《醫學微生物學和免疫學》（MMIM）發表關于傳染源和宿主免疫系統之間相互關系的所有方面的重要發現。該期刊的主要重點是針對病毒、細菌、真菌和寄生蟲（原生動物和蠕蟲）感染的內在、先天或適應性免疫反應以及相應傳染性病原體的毒力的原創研究工作。

MMIM 涵蓋傳染病和傳染病免疫學的基礎、轉化和臨床研究。歡迎使用細胞培養物、類器官和動物模型進行基礎研究，前提是這些模型具有臨床相關性并解決相關的醫學問題。

該期刊還考慮有關傳染病流行病學的稿件，包括病原體的出現和流行性傳播以及對抗感染療法的耐藥性的發展，以及新型疫苗和其他創新預防措施。

以下類別的稿件將不考慮在 MMIM 上發表：

提交初步工作，僅提供描述性數據集而未進行機制研究或全球關注度有限的稿件，

關于現有或新型抗感染化合物的稿件，重點關注藥物的藥學或藥理學方面，

關于現有或改良疫苗的稿件，除非它們報告了實驗或臨床療效研究或提供了有關其作用方式的新免疫學信息，

關于傳染病診斷的稿件，除非它們提供了解決傳染病診斷的新概念待定的診斷問題，

病例報告或病例系列，除非它們嵌入在專注于抗感染免疫反應和/或病原體毒力的研究中。

Medical Microbiology And Immunology創刊于1886年，由Springer Berlin Heidelberg出版商出版，收稿方向涵蓋醫學 - 免疫學全領域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 約1.0個月 ，影響因子指數5.5，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。